Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

CLGY Insider Trading

CLGY | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at CLGY provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2006-12-28 14:04 2006-12-27 ROTHERMEL ROBERT B Director SELL $1,100.00 20,000 $22,000,000 0 -100.0%
2006-12-28 03:13 2006-12-27 WILLIAMS RICHARD C Director SELL $540.00 10,000 $5,400,000 20,000 -33.3%
2006-12-22 21:31 2006-12-20 ROTHERMEL ROBERT B Director SELL $825.00 15,000 $12,375,000 20,000 -42.9%
2006-12-23 01:15 2006-12-22 ADAMS JOHN Q Director SELL $1,000.00 20,000 $20,000,000 0 -100.0%
2005-11-22 05:44 2005-11-17 CHANDLER JOHN J Officer - VP, Corporate Development SELL $0.71 5,000 $3,550 10,000 -33.3%
2005-05-16 22:37 2005-05-12 ROTHERMEL ROBERT B Director BUY $2.13 20,000 $42,600 35,000 +133.3%
2005-05-16 22:28 2005-05-12 WILLIAMS RICHARD C Director, Officer - Interim CEO BUY $2.13 20,000 $42,600 30,000 +200.0%
2005-05-16 23:14 2005-05-12 GREGORY JOHN M 10% owner BUY $1.65 225,000 $371,250 7,053,993 +3.3%
2005-05-17 02:45 2005-05-12 TISCH THOMAS J 10% owner BUY $0.00 644,000 $0 899,422 +252.1%
2005-05-16 22:44 2005-05-12 ADAMS JOHN Q Director BUY $2.13 10,000 $21,300 20,000 +100.0%
2004-12-29 22:23 2004-12-29 KARLIN DAVID A Officer - VP, Clinical Research SELL $2.73 2,000 $5,460 0 -100.0%
2004-12-28 21:44 2004-12-27 CHANDLER JOHN J Officer - VP, Corporate Development SELL $2.63 3,200 $8,416 15,000 -17.6%
2004-11-09 00:47 2004-11-05 KARLIN DAVID A Officer - Vice President OPT+S $5.02 6,000 $30,100 0 0.0%
2004-11-06 01:01 2004-11-03 JUELIS A RICHARD Officer - Vice President SELL $4.96 26,700 $132,416 6,820 -79.7%
2004-11-05 01:30 2004-10-25 JUELIS A RICHARD Officer - Vice President SELL $4.81 1,800 $8,662 33,520 -5.1%
2004-11-05 01:04 2004-11-02 KARLIN DAVID A Officer - Vice President SELL $4.88 14,000 $68,380 6,000 -70.0%
2004-11-05 00:50 2004-10-21 KARLIN DAVID A Officer - Vice President SELL $4.99 7,500 $37,455 20,000 -27.3%
2004-11-05 00:33 2004-10-22 KARLIN DAVID A Officer - Vice President SELL $5.00 2,500 $12,502 20,000 -11.1%
2004-11-05 00:01 2004-10-15 KARLIN DAVID A Officer - Vice President SELL $4.80 5,000 $24,000 20,000 -20.0%
2004-10-28 22:58 2004-10-21 KARLIN DAVID A Officer - Vice President SELL $4.99 7,500 $37,455 5,000 -60.0%
2004-10-26 19:53 2004-10-22 JUELIS A RICHARD Officer - VP, Finance & CFO SELL $4.91 4,000 $19,644 29,520 -11.9%
2004-10-26 20:11 2004-10-22 KARLIN DAVID A Officer - VP, Clinical Research SELL $5.00 2,500 $12,502 12,500 -16.7%
2004-10-16 00:30 2004-10-15 KARLIN DAVID A Officer - VP, Clinical Research SELL $4.80 5,000 $24,000 15,000 -25.0%
2004-08-12 23:06 2004-08-11 ADAMS JOHN Q Director BUY $3.60 7,000 $25,205 10,000 +233.3%
2004-07-29 22:21 2004-07-27 GREGORY JOHN M 10% owner BUY $3.42 1,000,000 $3,419,000 6,828,993 +17.2%
2004-07-30 01:46 2004-07-27 TISCH DANIEL R 10% owner BUY $3.42 150,000 $512,850 734,508 +25.7%
2004-07-30 01:45 2004-07-27 TISCH THOMAS J 10% owner BUY $3.42 150,000 $512,850 782,208 +23.7%
2004-07-30 01:46 2004-07-27 TISCH JAMES S 10% owner BUY $3.42 150,000 $512,850 734,508 +25.7%
2004-07-30 01:47 2004-07-27 TISCH ANDREW H 10% owner BUY $3.42 150,000 $512,850 734,508 +25.7%
2004-01-31 00:00 2004-01-29 ROTHERMEL ROBERT B Director BUY $5.95 5,000 $29,750 15,000 +50.0%
2004-01-30 00:22 2004-01-28 GREGORY JOHN M 10% owner BUY $5.92 689,656 $4,079,315 5,828,993 +13.4%
2004-01-28 01:38 2004-01-27 GREGORY JOHN M 10% owner BUY $5.86 255,007 $1,495,438 5,139,337 +5.2%
2003-11-25 23:32 2003-11-24 ADAMS JOHN Q Director BUY $2.89 3,000 $8,670 3,000 +100.0%
2003-11-24 19:58 2003-11-21 WILLIAMS RICHARD C Director BUY $2.79 10,000 $27,916 10,000 +100.0%
SHOW ENTRIES

How to Interpret $CLGY Trades

Not every insider transaction in CLGY is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $CLGY shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for CLGY

Insider activity data for CLGY is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $CLGY, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.